Is Hybio Pharmaceutical Co Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Hybio Pharmaceutical Co Ltd (300199.SZ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Hybio Pharmaceutical Co Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Hybio Pharmaceutical Co Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Hybio Pharmaceutical Co Ltd?

Muslim investors may consider investing in Hybio Pharmaceutical Co Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Hybio Pharmaceutical Co Ltd classified as NOT COVERED?

Musaffa determines the Shariah status of Hybio Pharmaceutical Co Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Hybio Pharmaceutical Co Ltd updated?

The Shariah compliance status of Hybio Pharmaceutical Co Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Hybio Pharmaceutical Co Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Hybio Pharmaceutical Co Ltd?

You can check the latest Shariah compliance status of Hybio Pharmaceutical Co Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Hybio Pharmaceutical Co Ltd 300199.SZ

Last Updated: May 15, 12:00 AM·SZSE

Hybio Pharmaceutical Co Ltd. Stock Analysis 300199.SZ

China Health Care Mid Cap

Hybio Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sales of chemically synthesized peptide drugs. The company is headquartered in Shenzhen, Guangdong. The company went IPO on 2011-04-07. The firm's main products include peptide preparations, peptide active pharmaceutical ingredients, customized peptides, beauty peptides, solid preparations, medical devices, peptide skincare products, and health products. The firm's products are mainly used in the digestive system, hemostasis, obstetrics and gynecology, cardiovascular and other fields. The firm mainly operates its businesses in the domestic and overseas markets.

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.

I accept the above